Press Releases

Press Releases

Bioventus, a global leader in orthobiologic solutions, today announced it has entered into a multi-year agreement with IBSA (Institut Biochimique SA), a pharmaceutical company based in Switzerland, to secure the exclusive US distribution rights for GELSYN-3™, a three-injection, hyaluronic acid (HA) product for pain relief associated with osteoarthritis (OA) of…

Press Releases

Bristol-Myers Squibb Company today announced that it has completed the previously announced sale of its HIV R&D portfolio to ViiV Healthcare, which includes a number of programs at different stages of discovery, preclinical and clinical development. Bristol-Myers Squibb received from ViiV Healthcare a payment of $350 million in connection with…

Press Releases

Northwestern Medicine interventional cardiologists at Northwestern Memorial Hospital are the first in the Midwest and second in the United States to repair a "leaky" tricuspid heart valve using the Trialign system, an investigational device that allows patients to forgo open heart surgery while still repairing the malfunctioning valve. "A minimally…

Press Releases

Anacor Pharmaceuticals, Inc. will release its financial results for the fourth quarter and year ended December 31, 2015, after the market closes on Monday, February 29, 2016. The announcement will be followed by a conference call at 5:00 p.m. ET / 2:00 p.m. PT during which management will discuss Anacor’s…

Press Releases

NuGEN Technologies, Inc. announced the launch of the Ovation® SoLo RNA-Seq System, the company’s latest tool in its suite of sample preparation products supporting research in areas previously hampered by sample input limitations such as single cells and liquid biopsy. The Ovation® SoLo kit will facilitate research in areas such…

Press Releases

US-Australian drug discovery company, Novogen Limited today announced that a patent for the superbenzopyran (SBP) family, covering the lead candidates Cantrixil and Trilexium, has been granted in Australia. This patent provides full protection of Novogen's intellectual property (IP) for the SBP family until 2035. In addition, the key patent application…

Friday, Feb 19, 2016
Press Releases

The board of directors of AbbVie Inc. declared a quarterly cash dividend of $0.57 per share. The cash dividend is payable May 16, 2016 to stockholders of record at the close of business on April 15, 2016. Since the company's inception in 2013, AbbVie has increased its dividend by more…

Press Releases

GTx, Inc. announced that it will host a conference call and webcast to provide a corporate update and discuss the Company's fourth quarter and full year 2015 financial results on Thursday, March 3, 2016 at 9:00 a.m. Eastern Time. The call and webcast will follow the release of the financial…

Press Releases

PAREXEL International Corporation, a leading global biopharmaceutical services organization, today announced expanded services and capabilities in genomic-based drug development. The PAREXEL® Genomic Medicine team offers clients a variety of strategic and operational genomic research services to accelerate drug development and to support regulatory and payer approval processes. Biopharmaceutical companies are…

Press Releases

Endo International plc announced the initiation of its Phase 2b study of collagenase clostridium histolyticum (or "CCH") for the treatment of edematous fibrosclerotic panniculopathy ("EFP"), commonly known as cellulite. CCH is known in its currently approved indications in the U.S. as XIAFLEX®. "Cellulite affects millions of U.S. women, dimpling their…